BENSALEM, Pa., Jan. 13 /PRNewswire-FirstCall/ -- Stelex, a subsidiary of Vital Signs, Inc. , today announced that it has appointed Michael Khavinson as its new President.
Mr. Khavinson, a founding partner of Stelex, has over 18 years experience in strategic business management. He has held a wide variety of positions in the Medical Device and Consulting Industries. Most recently, he has served as the Executive Vice President of Global Marketing and Strategic Planning for Vital Signs, Inc. Mr. Khavinson holds a Bachelor of Arts degree in Computer Science from Temple University.
“I am looking forward to this exciting opportunity,” Mr. Khavinson said. “Stelex is an enterprise-wide service organization. We are positioned to build on our success, to help our clients with a broad spectrum of regulatory solutions. Our goal is to become the most respected consulting firm in the regulated market, serving Pharmaceutical, Medical Device, Diagnostic and Biotechnology companies.”
“We are delighted that Michael will be leading Stelex,” said Terry D. Wall, President and CEO of Vital Signs. “His experience and perspective in the industry, knowledge of the regulatory consulting business, and his relationships within the industry will be beneficial to Stelex, our clients, and business partners.”
Stelex is a leading provider of enterprise-wide compliance services and solutions to the regulated industries including the Pharmaceutical, Medical Device, Diagnostic and Biotechnology sectors. The company delivers a comprehensive suite of Validation, Technology, Regulatory and Business solutions. To learn about Stelex, visit http://www.stelex.com/.
Vital Signs, Inc. and its subsidiaries design, manufacture and market primarily single-use medical products for the anesthesia, respiratory/critical care and sleep/ventilation markets, achieving the number one market share position in five of its major product categories. In addition, we provide pharmaceutical technology services to the pharmaceutical and medical device industry. The Company was recognized in the October 2003 and the October 2002 issues of Forbes Magazine as one of “The 200 Best Small Companies”. Vital Signs is ISO 9001 certified and has CE Mark approval for its products.
All statements in this press release other than historical statements constitute Forward-Looking Statements under the Private Securities Litigation Reform Act of 1995. Actual results could differ materially from such statements as a result of a variety of factors, including factors referred to by Vital Signs in its Annual Report on Form 10-K for the year ended September 30th, 2004.
CONTACT: Lalitha Sarma Stelex Phone: 215-352-1122 lsarma@stelex.comhttp://www.stelex.com/
Stelex
CONTACT: Lalitha Sarma, Stelex, +1-215-352-1122, lsarma@stelex.com
Web site: http://www.stelex.com/
